Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Verona Pharma plc buy Wells Fargo & Company

Start price
€0.51
15:01 / 50%
Target price
€45.31
03.10.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 03.10.25. The prediction end date can be changed by Wells_Fargo___Compan at any time.
Performance without dividends (%)
Name 1w
Verona Pharma plc -
iShares Core DAX® 1.308%
iShares Nasdaq 100 -0.156%
iShares Nikkei 225® 1.270%
iShares S&P 500 0.476%

Comments by Wells_Fargo___Compan for this prediction

In the thread Verona Pharma plc diskutieren
Prediction Buy
Perf. (%) -
Target price 45.305
Change
Ends at 03.10.25

Verona Pharma plc (NASDAQ: VRNA) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $50.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat